Skip to content

Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension

Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension: Effects of DASH Diet and Physical Activity on Blood Pressure and Insulin Sensitivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04863755
Enrollment
37
Registered
2021-04-28
Start date
2017-05-09
Completion date
2020-03-18
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Hypertension

Keywords

Diabetes, Hypertension, Elderly, DASH, Steps

Brief summary

Evaluate the effect of lifestyle modification through the adoption of a DASH diet, with and without physical activity guidance, on blood pressure and insulin sensitivity in elderly patients with type 2 diabetes and hypertension.

Detailed description

Data regarding the effects of physical activity and DASH-type diet on blood pressure control in patients with type 2 diabetes and hypertension are scarce in the literature, whether evaluating these isolated interventions or together. In addition, most studies do not measure BP using ABPM, which has a special importance in the assessment of pressure homeostasis in DM or are short-term studies. Were only two studies have been identified in the literature that evaluated the effect of the DASH diet on patients with type 2 DM; however, in both trials, being elderly was not an inclusion criterion. The first was an Iranian study that demonstrated in 31 non-hypertensive patients a significant reduction in BP after 8 weeks of following a DASH diet. In the second ECR, we demonstrated that in 20 hypertensive type 2 DM patients, all using antihypertensive drugs and with uncontrolled BP, a DASH-type diet for 4 weeks associated with physical activity reduced the systolic BP assessed by ABPM by 12.5 mmHg. However, the adopted design did not allow to separate the effect of diet from the effect of physical activity. On the other hand, the effect of a single session of walking followed by a 24-hour ABPM assessment showed a reduction in BP in hypertensive elderly and non-hypertensive patients, also without DM. So far it is not defined in patients with type 2 DM and hypertension, especially the elderly, whether the DASH diet alone is as beneficial for BP as its association with physical activity, particularly, considering the difficulties of performing exercises in this group of patients. This is valuable information, as it would reinforce the role of diet therapy intervention even if in isolation in this age group. Furthermore, the role of the DASH diet with or without physical activity remains unknown on insulin sensitivity.

Interventions

BEHAVIORALDASH

Patients receive DASH diet orientation and recommended to maintain their usual physical activity

BEHAVIORALDASHPED

Patients receive DASH diet orientation and recommended to increase their usual activity with the use of a pedometer

Sponsors

Federal University of Health Science of Porto Alegre
CollaboratorOTHER
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 60 years or more * Diabetes Mellitus * Hypertension with poor control

Exclusion criteria

* Glucocorticoid use * Unstable angina * Acute myocardial infarction in the last 6 months * Heart failure classes III and IV * history of cirrhosis, alcoholism or use of illicit drugs * Dementia and malignant disease that compromises survival in 5 years * Serum creatinine greater than 2, 0mg / dl * BMI\> 40 kg / m² * Physical disability that prevents the use of a pedometer * Participating in another research project involving any type of intervention.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Blood Pressure at 4 monthsBaseline and 4 months24 hours ambulatory blood pressure monitoring (ABPM)

Secondary

MeasureTime frameDescription
Change from Baseline Glucose Profile at 4 monthsBaseline and 4 monthsFasting glucose and A1C
Change from Baseline Weight at 4 months anthropometric variablesBaseline and 4 monthsweight in kilograms
Change from Baseline BMI at 4 monthsBaseline and 4 monthsBMI in kg/m2
Change from Baseline Skeletal muscle mass at 4 monthsBaseline and 4 monthsSkeletal muscle mass in Kilograms
Change from Baseline Body fat mass at 4 monthsBaseline and 4 monthsBody fat mass in kilograms
Change from Baseline Insulin Sensitivity at 4 monthsBaseline and 4 monthsHOMA index (using serum fasting insulin and glucose)
Change from Baseline Total cholesterol at 4 monthsBaseline and 4 monthsTotal cholesterol in mg/dl
Change from Baseline LDL cholesterol at 4 monthsBaseline and 4 monthsLDL cholesterol in mg/dl
Change from Baseline Triglycerides at 4 monthsBaseline and 4 monthsTriglycerides in mg/dl
Change from Baseline HDL cholesterol at 4 monthsBaseline and 4 monthsHDL cholesterol in mg/dl
Change from Baseline Percent body Fat at 4 monthsBaseline and 4 monthsPercent body Fat (%)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026